Related Experiment Video
Updated: Aug 8, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer-BioNTech COVID-19 vaccination: A case
Shungo Yano1, Taiju Miyagami1, Takayuki Furusaka1
1Department of General Medicine Juntendo University Faculty of Medicine Tokyo Japan.
Abstract:
Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA-based coronavirus disease 2019 (COVID-19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution.
Related Concept Videos
Venous Thrombosis I: Introduction
Cross-reactivity
Allergic Reactions
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions

